Literature DB >> 17420255

c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages.

Sunao Takeshita1, Roberta Faccio, Jean Chappel, Ling Zheng, Xu Feng, Jason D Weber, Steven L Teitelbaum, F Patrick Ross.   

Abstract

The molecular mechanisms by which binding of monocyte/macrophage colony-stimulating factor to its receptor c-Fms promotes replication in primary macrophages are incompletely understood, as all previous studies involved overexpression of receptor mutants in transformed cells not endogenously expressing the receptor. To address this issue we retrovirally expressed, in bone marrow-derived macrophages, a chimeric receptor containing a range of tyrosine to phenylalanine mutations in the c-Fms cytoplasmic tail. We measured incorporation of bromodeoxyuridine as a marker of proliferation and phosphorylation of ERKs, Akt, and the receptor itself. Our data indicate that tyrosine 559 is the major mediator of receptor activation and cell death, intracellular signaling, and cell proliferation and that the tyrosine residues at positions 697 and 807 play lesser roles in these events. Importantly, we find that activation of the ERK and Akt pathways is necessary but not sufficient for induction of macrophage proliferation. Using specific small molecule inhibitors we find that a combination of the Src family kinase, phosphatidylinositol 3-kinase/Akt, phospholipase C, and ERK pathways mediates macrophage proliferation in response to M-CSF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420255     DOI: 10.1074/jbc.M610938200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.

Authors:  Yuji Ito; Steven L Teitelbaum; Wei Zou; Yi Zheng; James F Johnson; Jean Chappel; F Patrick Ross; Haibo Zhao
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 2.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

3.  DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.

Authors:  Wei Zou; Jennifer L Reeve; Yuli Liu; Steven L Teitelbaum; F Patrick Ross
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

4.  A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation.

Authors:  Ying Xiong; Da Song; Yunfei Cai; Wenfeng Yu; Yee-Guide Yeung; E Richard Stanley
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

5.  CSF-1-induced Src signaling can instruct monocytic lineage choice.

Authors:  Max Endele; Dirk Loeffler; Konstantinos D Kokkaliaris; Oliver Hilsenbeck; Stavroula Skylaki; Philipp S Hoppe; Axel Schambach; E Richard Stanley; Timm Schroeder
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

Review 6.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

7.  IL-12 could induce monocytic tumor cells directional differentiation.

Authors:  Ting-Ting Ma; Bi-Tao Wu; Yan Lin; Hai-Yu Xiong; Qin Wang; Zi-Wei Li; Feng Cheng; Zhi-Guang Tu
Journal:  Mol Cell Biochem       Date:  2015-01-07       Impact factor: 3.396

8.  Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807.

Authors:  Wenfeng Yu; Jian Chen; Ying Xiong; Fiona J Pixley; Yee-Guide Yeung; E Richard Stanley
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

9.  Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo.

Authors:  Lei Wang; Bin Fang; Toshifumi Fujiwara; Kimberly Krager; Akshita Gorantla; Chaoyuan Li; Jian Q Feng; Michael L Jennings; Jian Zhou; Nukhet Aykin-Burns; Haibo Zhao
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

10.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.